Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments

Details for Australian Patent Application No. 2005274494 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Werner, Ulrich; Defossa, Elisabeth; Schoenafinger, Karl; Tschank, Georg; Jaehne, Gerhard; Buning, Christian

Agent Watermark

Pub. Number AU-A-2005274494

PCT Pub. Number WO2006/018117

Priority 10 2004 039 507.1 14.08.04 DE

Filing date 30 July 2005

Wipo publication date 23 February 2006

International Classifications

C07D 473/08 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/522 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/018117 Priority application(s): WO2006/018117

27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274495-2 - {-3-`2-(phenyl)-oxazol-4-ylmethoxymeth yl!-cyclohexylmethoxy}-propionic acid derivatives used as PPAR ligandes (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes

2005274493-N- (phenyl-oxazol-4-ylmethoxymethyl)-cycl ohexyl-succinic acid amide derivatives and related compounds which are used as PPAR-ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes